Wells Fargo & Company Abb Vie Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Abb Vie Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 9,173,863 shares of ABBV stock, worth $1.64 Billion. This represents 0.42% of its overall portfolio holdings.

Number of Shares

9,173,863

Previous 9,338,890 1.77%

Holding current value

$1.64 Billion

Previous $1.6 Billion 13.1%

% of portfolio

0.42%

Previous 0.39%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $27 Million - $32.9 Million	-165,027 Reduced 1.77%	9,173,863 $1.81 Billion
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $49.1 Million - $57.3 Million	317,245 Added 3.52%	9,338,890 $1.6 Billion
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $16.1 Million - $18.4 Million	-100,911 Reduced 1.11%	9,021,645 $1.64 Billion
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $32 Million - $36 Million	-232,584 Reduced 2.49%	9,122,556 $1.41 Billion
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $31.5 Million - $36.5 Million	-235,881 Reduced 2.46%	9,355,140 $1.39 Billion
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $23.4 Million - $29.1 Million	-176,663 Reduced 1.81%	9,591,021 $1.29 Billion
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $13.8 Million - $15.9 Million	-95,631 Reduced 0.97%	9,767,684 $1.56 Billion
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $85.2 Million - $102 Million	615,919 Added 6.66%	9,863,315 $1.59 Billion
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.85 Million - $2.12 Million	13,803 Added 0.15%	9,247,396 $1.24 Billion
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $118 Million - $150 Million	-860,039 Reduced 8.52%	9,233,593 $1.41 Billion
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $46.6 Million - $57.8 Million	352,890 Added 3.62%	10,093,632 $1.64 Billion
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $193 Million - $244 Million	-1,795,704 Reduced 15.57%	9,740,742 $1.32 Billion
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $33.8 Million - $38.4 Million	-318,079 Reduced 2.68%	11,536,446 $1.24 Billion
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $25.2 Million - $28.1 Million	239,340 Added 2.06%	11,854,525 $1.34 Billion
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $60.1 Million - $66.2 Million	587,452 Added 5.33%	11,615,185 $1.26 Billion
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $48.3 Million - $65.2 Million	599,875 Added 5.75%	11,027,733 $1.18 Billion
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $65.2 Million - $76.5 Million	-758,396 Reduced 6.78%	10,427,858 $913 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $148 Million - $199 Million	2,023,901 Added 22.09%	11,186,254 $1.1 Billion
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $591 Million - $896 Million	9,162,353 New	9,162,353 $698 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Abb Vie Inc. Transaction History